Evolution of 2014/15 H3N2 influenza viruses circulating in US: Consequences for vaccine effectiveness and possible new pandemic

Frontiers in Microbiology

Volumn 6, Issue DEC, 2015, Pages

  Veljkovic, Veljko ^a   Paessler, Slobodan ^b   Glisic, Sanja ^a   Prljic, Jelena ^a   Perovic, Vladimir R ^a   Veljkovic, Nevena ^a   Scotch, Matthew ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b University of Texas Medical Branch School of Medicine   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

H3N2; Influenza virus; Pandemic potential; Phylogenetic analysis; Seasonal influenza vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; BIOINFORMATICS; DRUG EFFICACY; EUROPE; INFLUENZA A VIRUS (H3N2); MATHEMATICAL MODEL; NONHUMAN; NORTH AMERICA; PHYLOGENY; SEASON; VIRUS MUTANT;

EID: 84954158386     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01456     Document Type: Article

References (18)

1. Center for Disease Control Prevention (2014a). Seasonal Influenza Vaccine Effectiveness, 2005-2015. Available online at: http://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm
2. 2) Viruses. Available online at: http://emergency.cdc.gov/HAN/han00374.asp
3. Center for Disease Control Prevention (2015a). Advisory Committee on Immunization Practices (ACIP) Reaffirms Recommendation for Annual Influenza Vaccination. Available online at: http://www.cdc.gov/media/releases/2015/s0226-acip.html
4. 2v by State Since August 2011. Available online at: http://www.cdc.gov/flu/swineflu/h3n2v-case-count.htm
5. Food Drug Administration (2014). Vaccines and Related Biological Products Advisory Committee Meeting Summary Minutes. Available online at: http://www.fda.gov/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/vaccinesandrelatedbiologicalproductsadvisorycommittee/ucm391605.htm
6. 2 influenza viruses in North American swine and humans, 2009-2011. J. Virol. 86, 8872-8878. doi: 10.1128/JVI.00259-12
7. Nobusawa, E., and Sato, K. (2006). Comparison of the mutation rates of human influenza A and B viruses. J. Virol. 80, 3675-3678. doi: 10.1128/JVI.80.7.3675-3678.2006
8. Pebody, R., Warburton, F., Ellis, J., Andrews, N., Thompson, C., von Wissmann, B., et al. (2015). Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Eurosurveillance 20:21025. doi: 10.2807/1560-7917.ES2015.20.5.21025
9. Perovic, V. (2013). Novel algorithm for phylogenetic analysis of proteins: application to analysis of the evolution of H5N1 influenza viruses. J. Mathem. Chem. 51, 2238-2255. doi: 10.1007/s10910-013-0212-1
10. Perovic, V. R., Muller, C. P., Niman, H. L., Veljkovic, N., Dietrich, U., Tosic, D. D., et al. (2013). Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission. PLoS ONE 8:e61572. doi: 10.1371/journal.pone.0061572
11. 1 influenza A viruses detected in pigs are virulent and antigenically distinct from endemic viruses. J. Virol. 89, 11213-11222. doi: 10.1128/JVI.01675-15
12. Schmier, S., Mostafa, A., Haarmann, T., Bannert, N., Ziebuhr, J., Veljkovic, V., et al. (2015). In Silico prediction and experimental confirmation of HA residues conferring enhanced human receptor specificity of H5N1 influenza A viruses. Sci. Rep. 5:11434. doi: 10.1038/srep11434
13. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and Kumar, S. (2011). MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731-2739. doi: 10.1093/molbev/msr121
14. Veljkovic, V., Cosic, I., Dimitrijevic, B., and Lalovic, D. (1983). Is it possible to analyze DNA and protein sequence by the method of digital signal processing? IEEE Trans BME. 32, 337-340.
15. Veljkovic, V., Niman, H. L., Glisic, S., Veljkovic, N., Perovic, V., and Muller, C. P. (2009b). Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor. BMC Struct. Biol. 9, 62-72. doi: 10.1186/1472-6807-9-62
16. Veljkovic, V., Veljkovic, N., Muller, C. P., Müller, S., Glisic, S., Perovic, V., et al. (2009a). Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control. BMC Struct. Biol. 9:21. doi: 10.1186/1472-6807-9-21
17. Vergara-Alert, J., Argilaguet, J. M., Busquets, N., Ballester, M., Martín-Valls, G. E., Rivas, R., et al. (2012). Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model. PLoS ONE. 7:e40524. doi: 10.1371/journal.pone.0040524
18. World Health Organization (2015). Recommended Composition of Influenza Virus Vaccines for Use in the 2015-2016 Northern Hemisphere Influenza Season. Available online at: http://www.who.int/influenza/vaccines/virus/recommendations/2015_16_north/en